These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 23611755

  • 1. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U, Kaths JM, Heise M, Pitton MB, Weinmann A, Hoppe-Lotichius M, Otto G.
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [Abstract] [Full Text] [Related]

  • 2. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [Abstract] [Full Text] [Related]

  • 3. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
    Wu ZF, Zhang HB, Yang N, Zhao WC, Fu Y, Yang GS.
    Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.
    Hepatogastroenterology; 2002 Jul; 49(44):311-6. PubMed ID: 11995440
    [Abstract] [Full Text] [Related]

  • 5. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [Abstract] [Full Text] [Related]

  • 6. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, Iguchi T, Kayashima H, Sugimachi K, Maehara Y.
    Anticancer Res; 2008 Nov; 28(4C):2353-9. PubMed ID: 18751418
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ, Liang LJ, Hua YP, Peng BG, He Q, Lu MD, Chen D.
    Chin Med J (Engl); 2009 Oct 05; 122(19):2286-91. PubMed ID: 20079127
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.
    Ann Surg Oncol; 2010 Jul 05; 17(7):1816-22. PubMed ID: 20135355
    [Abstract] [Full Text] [Related]

  • 9. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM.
    Ann Surg Oncol; 2010 Jul 05; 17(7):1823-30. PubMed ID: 20165987
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.
    J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F.
    Ann Surg Oncol; 2009 Feb 01; 16(2):404-12. PubMed ID: 19037702
    [Abstract] [Full Text] [Related]

  • 12. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
    Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, Monden M.
    J Hepatobiliary Pancreat Surg; 2008 Feb 01; 15(4):417-22. PubMed ID: 18670844
    [Abstract] [Full Text] [Related]

  • 13. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug 01; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]

  • 14. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M.
    Ann Surg; 2006 Aug 01; 244(2):230-9. PubMed ID: 16858185
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K.
    Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618
    [Abstract] [Full Text] [Related]

  • 19. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
    Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y.
    Ann Surg; 2013 Jul 15; 258(1):129-40. PubMed ID: 23059502
    [Abstract] [Full Text] [Related]

  • 20. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.
    Zhu HF, Li J, Huang L, Yan YQ.
    Hepatogastroenterology; 2013 Jul 15; 60(122):263-7. PubMed ID: 23574653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.